Immunologix is a human antibody development company founded on a proprietary technology that transforms naïve B-cells into fully human monoclonal antibodies targeting any antigen.

Charleston Ear, Nose and Throat and SC Launch Company Immunologix, Inc. Team Up to Supply Human Tonsil Tissue for Lifesaving Research
Thomson Reuters Pharma publishes review by Immunologix
Immunologix partnered with Biorbis to be the lead sponsor of the 2010 US Antibody Engineering and Design Conference in July...